Summa Equity Fund II has acquired Axion BioSystems, a US life science tools business specializing in the development, production, and marketing of MEA (Microelectrode Arrays) and impedance technologies. Its tools are used to understand cell behavior and function in real-time, for applications including cell and gene therapy (CGT). Stockholm, Sweden: Summa Equity Fund II (“Summa”) has […]
Million-Cell Experiments Routinely Accessible for the First Time PLEASANTON, Calif. — Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new Chromium X Series, a next-generation platform for single cell analysis. The new Series comprises the Chromium X, the company’s most powerful instrument yet […]
SYDNEY — Inventia Life Science and PhenoVista Biosciences have secured a strategic partnership to super-charge 3D cell biology research services with the installation of Inventia’s 3D Cell Culture Platform – RASTRUM™ – at PhenoVista’s California site. This addition to PhenoVista’s instrument portfolio will help complement the company’s existing expertise in high content imaging and phenotypic assays by providing […]
Cardea Bio, a Tech+Bio company that has integrated molecular biology with semiconductor electronics, today announced that Dawn Barry has joined the company’s Board of Directors. Dawn Barry is the President & co-founder of LunaPBC, Inc., which was named by the World Economic Forum as a Technology Pioneer in 2019. SAN DIEGO — Cardea technology taps […]
Supports accelerated growth of R&D, manufacturing, and commercial activities with new 100,000 sq-ft state-of-the-art facility Reinforces commitment to the region as Abcam approaches 20 years of US presence Cambridge, UK: Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA. The new facility […]
SHANGHAI — Sequanta Technologies Co., Ltd. (“Sequanta”) and Mission Bio. (“Mission Bio”) are pleased to announce that they have entered into a strategic partnership, providing high-quality single-cell sequence services using Mission Bio’s products to customers in mainland China. With this new and important collaboration, customers in China will have access to run Mission Bio fee-for-service projects in a similar […]
About the partnership Brussels, Belgium – Ovizio Imaging Systems, a manufacturer of cell analyzers for advanced monitoring in the bioprocessing market, and BCC, an organization providing training, research services, and design of infrastructures for biopharmaceutical production, today announced that they will enter into a collaboration to broaden the range of monitoring tools for the bioprocessing industry. […]
New media panel, gene kit and advanced resins help reduce manufacturing costs while increasing the viability of gene therapies CARLSBAD, Calif. — For gene therapy developers seeking to rapidly and efficiently scale production, a set of solutions is now available from Thermo Fisher Scientific to support adeno-associated viral (AAV) manufacturing. A new media panel, gene kit and […]
Horizon Discovery is proud to announce that we are collaborating with YCharOS, Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins, as members of YCharOS’s newly formed Industry Advisory Committee (IAC). The role of the IAC is to support YCharOS in realizing its purpose to enable users […]
VectorBuilder – a global leader in vector design, optimization and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production. VectorBuilder’s manufacturing center in Guangzhou, China, will work with Univercells Technologies to develop and optimize platform processes for the production […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
